Mark Hvistendahl

631 total citations
27 papers, 469 citations indexed

About

Mark Hvistendahl is a scholar working on Nutrition and Dietetics, Physiology and Surgery. According to data from OpenAlex, Mark Hvistendahl has authored 27 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Nutrition and Dietetics, 13 papers in Physiology and 8 papers in Surgery. Recurrent topics in Mark Hvistendahl's work include Clinical Nutrition and Gastroenterology (23 papers), Diet and metabolism studies (9 papers) and Gastrointestinal motility and disorders (8 papers). Mark Hvistendahl is often cited by papers focused on Clinical Nutrition and Gastroenterology (23 papers), Diet and metabolism studies (9 papers) and Gastrointestinal motility and disorders (8 papers). Mark Hvistendahl collaborates with scholars based in Denmark, United Kingdom and France. Mark Hvistendahl's co-authors include Palle Bekker Jeppesen, Rahim M. Naimi, Christopher F. Brandt, Siri Tribler, Michael Staun, Jens J. Holst, Jan Lysgaard Madsen, Bolette Hartmann, Lotte Hahn Enevoldsen and Federico Bolognani and has published in prestigious journals such as Gastroenterology, Metabolism and Clinical Nutrition.

In The Last Decade

Mark Hvistendahl

25 papers receiving 464 citations

Peers

Countries citing papers authored by Mark Hvistendahl

Since Specialization

Citations

This map shows the geographic impact of Mark Hvistendahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hvistendahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hvistendahl more than expected).

Fields of papers citing papers by Mark Hvistendahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hvistendahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hvistendahl. The network helps show where Mark Hvistendahl may publish in the future.

Co-authorship network of co-authors of Mark Hvistendahl

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hvistendahl. A scholar is included among the top collaborators of Mark Hvistendahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hvistendahl. Mark Hvistendahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Transferability of metabolic balance studies in short bowel syndrome 2025 ·Clinical Nutrition ESPEN ·(unknown), Johan Hviid Andersen, Mark Hvistendahl, Joran Tóth, (unknown), (unknown), Francisca Joly, Kristin Verbeke, Palle Bekker Jeppesen, Tim Vanuytsel	1
2	Outcomes of glepaglutide on intestinal absorption and parenteral support in patients with short bowel syndrome 2025 ·Clinical Nutrition ESPEN ·(unknown), Thor Schütt Svane Nielsen, (unknown), Mark Hvistendahl, (unknown), Palle Bekker Jeppesen	0
3	Fat absorption and metabolism after Roux-en-Y gastric bypass surgery 2025 ·Metabolism ·(unknown), Anne‐Marie Lundsgaard, (unknown), (unknown), Nora Hedbäck, Maria S. Svane, Carsten Dirksen, Nils B. Jørgensen, (unknown), Palle Bekker Jeppesen, Mark Hvistendahl, Christina Christoffersen, Hartwig R. Siebner, Bente Kiens, Jens J. Holst, Sten Madsbad, Gerrit van Hall, Kirstine N. Bojsen‐Møller	1
4	Protein-based oral rehydration solutions for patients with an ileostomy: A randomised, double-blinded crossover study 2024 ·Clinical Nutrition ·(unknown), Mark Hvistendahl, Bente Langdahl, (unknown), Simon Mark Dahl Baunwall, Simon Lal, Palle Bekker Jeppesen, Christian Lodberg Hvas	1
5	Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon–in–continuity: A multicenter, open-label, metabolic balance study 2024 ·Clinical Nutrition ·(unknown), Mark Hvistendahl, Federico Bolognani, (unknown), Nader N. Youssef, Susanna Y. Huh, Alex Menys, Gauraang Bhatnagar, Ragna Vanslembrouck, Ronald Peeters, Riccardo Sartoris, Pieter Vermeersch, Lucas A. Wauters, Kristin Verbeke, Palle Bekker Jeppesen, Francisca Joly, Tim Vanuytsel	3
6	Post-prandial secretion of glucagon-like peptide-2 (GLP-2) after carbohydrate-, fat- or protein enriched meals in healthy subjects 2023 ·Peptides ·(unknown), Mark Hvistendahl, Christopher F. Brandt, Paul Blanche, Bolette Hartmann, Jens J. Holst, Palle Bekker Jeppesen	5
7	Effects of glepaglutide, a long‐acting glucagon‐like peptide‐2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial 2022 ·Journal of Parenteral and Enteral Nutrition ·Rahim M. Naimi, Mark Hvistendahl, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus, Michael Patrick Achiam, Lars Bo Svendsen, Palle Bekker Jeppesen	14
8	Apraglutide, a novel once‐weekly glucagon‐like peptide‐2 analog, improves intestinal fluid and energy absorption in patients with short bowel syndrome: An open‐label phase 1 and 2 metabolic balance trial 2022 ·Journal of Parenteral and Enteral Nutrition ·(unknown), Mark Hvistendahl, (unknown), Federico Bolognani, Christian P. Meyer, Palle Bekker Jeppesen	17
9	Effect of Glepaglutide, a Long‐Acting Glucagon‐Like Peptide‐2 Analog, on Gastrointestinal Transit Time and Motility in Patients With Short Bowel Syndrome: Findings From a Randomized Trial 2020 ·Journal of Parenteral and Enteral Nutrition ·Mark Hvistendahl, Rahim M. Naimi, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Palle Bekker Jeppesen	33
10	Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial 2019 ·EBioMedicine ·Rahim M. Naimi, Mark Hvistendahl, Nikolaj Nerup, Rikard Ambrus, Michael Patrick Achiam, Lars Bo Svendsen, Henning Grønbæk, Holger Jon Møller, Hendrik Vilstrup, Adam Steensberg, Palle Bekker Jeppesen	24
11	Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial 2019 ·The Lancet. Gastroenterology & hepatology ·Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Steen Seier Poulsen, Hannelouise Kissow, Jens Pedersen, Nikolaj Nerup, Rikard Ambrus, Michael Patrick Achiam, Lars Bo Svendsen, Jens J. Holst, Bolette Hartmann, Svend Høime Hansen, Lars Ove Dragsted, Adam Steensberg, Ulrik Mouritzen, Mark Berner Hansen, Palle Bekker Jeppesen	61
12	Repeated Metabolic Balance Studies in Patients With Short Bowel Syndrome 2019 ·Journal of Parenteral and Enteral Nutrition ·Haifeng Sun, (unknown), (unknown), Mark Hvistendahl, Rahim M. Naimi, Palle Bekker Jeppesen	6
13	Su1982 - Glepaglutide, a Glucagon-Like Peptide-2 Analog, Ameliorates Accelerated Gastrointestinal Transit Time in Patients with Short Bowel Syndrome 2018 ·Gastroenterology ·Mark Hvistendahl, Rahim M. Naimi, Lotte Hahn Enevoldsen, Jan Lysgaard Madsen, Stefan Fuglsang, Mark Berner Hansen, Palle Bekker Jeppesen	1
14	794 - Glepaglutide, a Long-Acting Glucagon-Like Peptide-2 Analog, Improves Intestinal Absorption of Macronutrients, Body Weight and Lean Body Mass in Patients with Short Bowel Syndrome 2018 ·Gastroenterology ·Mark Hvistendahl, Rahim M. Naimi, Mark Berner Hansen, Palle Bekker Jeppesen	1
15	Catheter‐Related Bloodstream Infections in Adults Receiving Home Parenteral Nutrition: Substantial Differences in Incidence Comparing a Strict Microbiological to a Clinically Based Diagnosis 2017 ·Journal of Parenteral and Enteral Nutrition ·Siri Tribler, Christopher F. Brandt, Mark Hvistendahl, Michael Staun, (unknown), Claus Moser, Palle Bekker Jeppesen	36
16	Fasting and Postprandial Plasma Citrulline and the Correlation to Intestinal Function Evaluated by 72‐Hour Metabolic Balance Studies in Short Bowel Jejunostomy Patients With Intestinal Failure 2017 ·Journal of Parenteral and Enteral Nutrition ·(unknown), Mark Hvistendahl, Palle Bekker Jeppesen	13
17	Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: The Evolution Over 4 Decades in a Tertiary Referral Center 2016 ·Journal of Parenteral and Enteral Nutrition ·Christopher F. Brandt, Mark Hvistendahl, Rahim M. Naimi, Siri Tribler, Michael Staun, (unknown), Palle Bekker Jeppesen	70
18	Home Parenteral Nutrition in Adult Patients With Chronic Intestinal Failure: Catheter‐Related Complications Over 4 Decades at the Main Danish Tertiary Referral Center 2016 ·Journal of Parenteral and Enteral Nutrition ·Christopher F. Brandt, Siri Tribler, Mark Hvistendahl, Rahim M. Naimi, (unknown), Michael Staun, Palle Bekker Jeppesen	47
19	Effect of Liraglutide Treatment on Jejunostomy Output in Patients With Short Bowel Syndrome: An Open‐Label Pilot Study 2016 ·Journal of Parenteral and Enteral Nutrition ·Mark Hvistendahl, Christopher F. Brandt, Siri Tribler, Rahim M. Naimi, Bolette Hartmann, Jens J. Holst, Jens F. Rehfeld, Mads Hornum, Jens Rikardt Andersen, Birthe Merete Henriksen, Preben Bo Mortensen, Palle Bekker Jeppesen	48
20	Single‐Center, Adult Chronic Intestinal Failure Cohort Analyzed According to the ESPEN‐Endorsed Recommendations, Definitions, and Classifications 2015 ·Journal of Parenteral and Enteral Nutrition ·Christopher F. Brandt, Siri Tribler, Mark Hvistendahl, Michael Staun, (unknown), Palle Bekker Jeppesen	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact